CNC up +1.02% percent right now. $CNC High is at 95.00 and

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
CNC up +1.02% percent right now. $CNC High is at 95.00 and the Low 93.55 with current volume of 320,154.

Recent News posted below.

CNC Centene Corp Recent Headline News

Cynthia Brinkley Joins Centene As Executive Vice President, International Operations & Business Integration
PR Newswire - Tue Nov 11, 9:29AM CST
Centene Corporation (NYSE: CNC) announced today that Cynthia J. Brinkley has joined the company as executive vice president, International Operations & Business Integration. In this new position, Brinkley will coordinate and direct Centene's international operations, which include its investments in Ribera Salud S.A., a Spanish health management group based in Valencia.
CNC: 94.77 (+1.02), GM: 31.25 (+0.13)

Could This Supreme Court Ruling Unravel Obamacare?
Sean Williams, The Motley Fool - Motley Fool - Tue Nov 11, 8:12AM CST
Source: White House on Flickr. Even though the Patient Protection and Affordable Care Act, which most Americans known better as Obamacare, was signed into law more than four years ago and has been fully implemented on the individual side of the...
CNC: 94.77 (+1.02), HCA: 65.83 (+0.08), ACN: 83.85 (-0.31), WLP: 126.54 (+1.04)

Centene Earnings In Retrospect: Up 3.5% in the Last 13 Days (CNC)
Comtex SmarTrend(R) - Mon Nov 10, 8:23AM CST
When Centene (NYSE:CNC) reported earnings a week ago on October 28th, 2014, analysts, on average, expected the company to report earnings of $0.99 on sales of $4.3 billion. Centene actually reported earnings of $1.07 per share on sales of $4.4 billion, beating EPS estimates by $0.08 and beating revenue estimates by $98.9 million. Shares of Centene have climbed from $88.65 to $91.72, representing a gain of 3.5% since the company reported earnings 13 days ago.
CNC: 94.77 (+1.02)

Centene Corporation To Provide 2015 Financial Guidance And Host Investor Meeting In NYC On December 12, 2014
PR Newswire - Mon Nov 10, 7:00AM CST
Centene Corporation (NYSE: CNC) today announced that it plans to release its 2015 financial guidance at approximately 6:00 AM (Eastern Time) on Friday, December 12, 2014, and host an investor meeting, including a question-and-answer session, to discuss the details of its guidance. The meeting will begin promptly at 8:30 AM and end approximately at 11:45 AM (Eastern Time), with breakfast and registration starting at 7:30 AM. Michael F. Neidorff, Chairman and Chief Executive Officer, and William N. Scheffel, Executive Vice President, Chief Financial Officer and Treasurer, of Centene Corporation will host the meeting, which will also be webcast live before an audience of institutional investors and analysts at the St. Regis Hotel, 2 East 55th Street at Fifth Avenue, in New York City.
CNC: 94.77 (+1.02)

These Companies Were Election Day Losers
Todd Campbell, The Motley Fool - Motley Fool - Sat Nov 08, 8:35AM CST
Source: Architect of the Capitol Flickr. The votes cast and counted, it appears that private Medicaid insurers including Centene , WellPoint , WellCare and UnitedHealth Group were among the losers. That's because those companies run...
CNC: 94.77 (+1.02), UNH: 95.56 (+0.81), WCG: 69.68 (-0.19), WLP: 126.54 (+1.04), MOH: 49.73 (+0.18)

Shares of CNC Up 12.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 07, 9:30AM CST
SmarTrend identified an Uptrend for Centene (NYSE:CNC) on October 23rd, 2014 at $83.00. In approximately 2 weeks, Centene has returned 12.13% as of today's recent price of $93.07.
CNC: 94.77 (+1.02)

IlliniCare Health Expands Leadership Team; Adds Two Executives
PR Newswire - Wed Nov 05, 8:00AM CST
IlliniCare Health, a subsidiary of Centene Corporation (NYSE: CNC), has expanded its leadership team to support its growing membership within Illinois. Michael Marrah has been named Chief Operations Officer (COO) and Angela Haggard has been appointed Vice President of Product Development.
CNC: 94.77 (+1.02)

Top Funds Buy Ulta Beauty, Alexion, Avago
at Investor's Business Daily - Tue Nov 04, 5:52PM CST
Managers of leading mutual funds in recent months have continued to stock up on large medical stocks, such as Illumina (ILMN), Alexion Pharmaceuticals (ALXN), Celgene (CELG), Jazz Pharmaceuticals (JAZZ),Allergan (AGN) and Centene (CNC). The...
AMBA: 49.36 (+0.15), MNST: 106.72 (-1.04), SWKS: 60.93 (-0.04), GMCR: 154.42 (-0.95), ILMN: 187.39 (-0.88), WSM: 67.37 (+0.71), NXPI: 73.95 (-0.44), CELG: 107.60 (-0.41), HAIN: 106.07 (-3.14), AGN: 194.98 (-0.26), CNC: 94.77 (+1.02), V: 249.25 (-0.96), CALM: 42.68 (+0.24), JAZZ: 171.81 (-2.62), ALXN: 195.20 (-0.60), LOW: 57.98 (+0.15), ULTA: 121.55 (-2.53), MA: 84.36 (-0.49), AVGO: 86.05 (+0.14), PETM: 72.29 (-0.45)

Centene, Humana, UnitedHealth, WellPoint in Focus Thanks to Obamacare
at The Street - Mon Nov 03, 3:18PM CST
It’s been a great year for health insurers thanks to the Affordable Care Act and Healthcare.gov and growth will likely exceed 20 percent in 2015, but is this priced-in.
CNC: 94.77 (+1.02), UNH: 95.56 (+0.81), WLP: 126.54 (+1.04), HUM: 135.22 (+2.76)

Aetna Adds To Retail Stance With Exchange Tech Buy
at Investor's Business Daily - Mon Nov 03, 12:25PM CST
Aetna (AET) said it is acquiring a technology platform that helps administer public and private health-insurance exchanges. The insurer will buy Bswift for $400 million in a transaction that will be funded by available Aetna resources and is expected...
CNC: 94.77 (+1.02), AET: 84.54 (+0.52), WLP: 126.54 (+1.04)

Start Smart For Your Baby Texting Program Wins Children's Health Award By Medicaid Health Plans of America
PR Newswire - Mon Nov 03, 7:00AM CST
Centene Corporation (NYSE: CNC) announced today that its Start Smart For Your Baby® Texting Program was awarded the Children's Health Award by the Medicaid Health Plans of America (MHPA). The Best Practices Awards honor Medicaid health plans for their exemplary programs which have improved the health of Medicaid enrollees by ensuring high-quality care.
CNC: 94.77 (+1.02)

Obamacare's Shocking Effect on Premium Prices
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 02, 7:08AM CST
Source: White House on Flickr. The Affordable Care Act, which is best known in its shorthand form as Obamacare, was developed with a couple of goals in mind. One was obviously to reduce the number of uninsured people in the U.S. The idea here is...
CNC: 94.77 (+1.02), MOH: 49.73 (+0.18)

3 Ways You Can Profit from Obamacare
Todd Campbell, The Motley Fool - Motley Fool - Sat Nov 01, 1:01PM CDT
Source: Centene Corp. The Affordable Care Act's second open enrollment period begins on Nov. 15 and expectations are that millions more Americans will use the federal and state exchanges to sign up for health insurance to avoid the health...
CNC: 94.77 (+1.02), HCA: 65.83 (+0.08), WLP: 126.54 (+1.04)

The 1 Factor That Could Send Obamacare Into a Death Spiral
Sean Williams, The Motley Fool - Motley Fool - Sat Nov 01, 7:38AM CDT
Source: White House on Flickr. Regardless of whether you're a proponent or opponent of the Affordable Care Act, better known as Obamacare, no one can deny that it's changed the healthcare landscape. For some lower-income citizens, it has provided...
CNC: 94.77 (+1.02), WLP: 126.54 (+1.04), MOH: 49.73 (+0.18)

Centene Corporation To Present At Credit Suisse 2014 Healthcare Conference
PR Newswire - Thu Oct 30, 3:27PM CDT
Centene Corporation (NYSE: CNC) announced today it will present at the Credit Suisse 2014 Healthcare Conference, to be held from November 10-13, 2014, at the Arizona Biltmore Hotel in Phoenix, AZ.
CNC: 94.77 (+1.02)

Can the Rally in Centene (CNC) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:03AM CDT
Can the Rally in Centene (CNC) Shares Continue?
CNC: 94.77 (+1.02)

Centene Rises 1.35% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Oct 29, 4:39PM CDT
Centene (NYSE:CNC) traded in a range yesterday that spanned from a low of $89.31 to a high of $92.16. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $89.48 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CNC: 94.77 (+1.02)

Indexes Mixed Ahead Of Fed Statement; Facebook Falls
at Investor's Business Daily - Wed Oct 29, 11:02AM CDT
Stocks were narrowly mixed in late-morning trading ahead of the upcoming policy statement from the Federal Open Market Committee meeting at 2 p.m ET. The Dow Jones industrial average and S&P 500 turned slightly higher, while the Nasdaq slid 0.4%....
CNC: 94.77 (+1.02), EA: 41.18 (-0.08), FB: 74.30 (-0.70), X: 35.03 (-1.67)

Stocks Close Strongly; Tesla Rebounds
at Investor's Business Daily - Tue Oct 28, 3:30PM CDT
A number of highly rated stocks hit new highs Tuesday as the major indices continued to rally. The Nasdaq led, rising 1.8%, while the S&P 500 climbed 1.3% and the Dow Jones industrial average 1.1%. Preliminary numbers showed volume was higher on both...
CNC: 94.77 (+1.02), TSLA: 249.05 (+7.12), KSS: 56.13 (-0.44), SAVE: 78.87 (-0.18), TYL: 109.61 (-0.43), FRGI: 55.65 (-0.86)

Stocks Tack On Gains; Centene Hits New High
at Investor's Business Daily - Tue Oct 28, 2:12PM CDT
Stocks added to gains late Tuesday afternoon. Techs continued to outperform. The Nasdaq jumped 1.4%, thanks to strength in chips, solar and security software stocks. The S&P 500 rose 0.8% and the Dow Jones industrial average climbed 0.7%. Volume was...
CNC: 94.77 (+1.02), GPRO: 74.40 (-1.35), ESRX: 77.71 (-0.28), SAVE: 78.87 (-0.18), EA: 41.18 (-0.08), PNRA: 168.62 (-0.69), FB: 74.30 (-0.70), TRN: 35.72 (-0.30), EXP: 88.22 (+0.33), WYNN: 179.75 (+1.86), WDC: 96.83 (-0.81), AAPL: 109.09 (+0.26), BABA: 115.45 (-3.70)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 352

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 37

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 163

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

BerGenBio Welcomes First Patient in Lung Cancer Study

Updated Category News Views 202

BerGenBio Embarks on Promising Lung Cancer Trial BerGenBio ASA, a clinical-stage biopharmaceutical company dedicated to combating serious diseases through innovative therapies, has reached a significant milestone in its journey. The company has successfully included the first patient in its clinical trial, focusing on the cutting-edge AXL kinase inhibitor known as...

Continue Reading
CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform

Updated Category News Views 247

CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform CIMG Inc. (NASDAQ: IMG), a dynamic group in the digital health and sales development sector, has officially launched its tokenized stock on the FlowStocks platform. This exciting development follows successful testing and represents a significant shift in how the company interacts with its investors. The new...

Continue Reading
Exploring the Impact of New SEC Leadership on Cryptocurrency

Updated Category News Views 179

New Era for Cryptocurrency Under SEC Leadership The recent changes at the Securities and Exchange Commission (SEC) under new leadership signal a transformative period for the cryptocurrency market. These developments could reshape the regulatory landscape, offering clarity and direction for investors and companies involved in the digital asset space. Understanding the...

Continue Reading
Shytoshi Kusama Transitions Roles: Shiba Inu's New Direction

Updated Category News Views 190

Shytoshi Kusama Transitions to New Leadership Role Shytoshi Kusama, the driving force behind the Shiba Inu ecosystem, has made a significant change by stepping down from his role as the lead visionary. This pivotal shift marks a transition to the position of lead ambassador, as he aims to spearhead global adoption more effectively. The Shift in Leadership Announcing his...

Continue Reading
BASF Shares Fall Following Proposed Dividend Cuts to Shareholders

Updated Category News Views 281

BASF (ETR:BASFN) just took a hit on its stock price after announcing some major shifts in its dividend policy. Shares plummeted by 2.9% to €44.035, all thanks to the company's new proposed minimum annual dividend of €2.25 per share for the upcoming 2024 business year. That’s a stark drop from the previous €3.40 per share they dished out in 2023—talk about making...

Continue Reading